Schechter Jonathan: insider buys
Every open-market stock purchase reported by Schechter Jonathan to the SEC on Form 4.
Total bought$67.30K
Purchases2
Companies2
Last purchase filedJan 7, 2026
Return on these buys-53%
Schechter Jonathan has made 2 open-market purchases worth $67.30K in 2 companies since Nov 17, 2025, according to SEC Form 4 filings. The most recent was filed on Jan 7, 2026: 60,000 shares of PMCB at $0.80 (Director), worth $48.20K. Taken together, these purchases are down 53% at the latest closing prices (split-adjusted, weighted by amount).
Companies Schechter Jonathan bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| PMCB | PharmaCyte Biotech, Inc. | Director | 1 | $48.20K | -53% | Jan 7 |
| OBLG | Oblong, Inc. | Director | 1 | $19.10K | — | Nov 17 |
Get the next Schechter Jonathan purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7 | PMCBPharmaCyte Biotech, Inc. | Schechter JonathanDirector | $48.20K | 60,000 | $0.80 | -53% | +45% | Jan 5 | SEC |
| Nov 17 | OBLGOblong, Inc. | Schechter JonathanDirector | $19.10K | 10,000 | $1.91 | — | +67% | Nov 14 | SEC |